Clinicopathological features of gastric carcinoma in Libyan patients: National cancer institute Sabratha based study
DOI:
https://doi.org/10.54361/ljmr.16.2b.04Keywords:
Gastric cancer, Clinicopathological features, national cancer institute sabratha , LibyaAbstract
Gastric cancer (GC) remains an important cancer worldwide and it is estimated that there will be over 1 089 103 new cases (representing 5.6% of all cancer cases diagnosed) and 768793 deaths ( 8.2% of all deaths from cancer ) in 2020, making it the fifth most frequently diagnosed cancer and the third leading cause of cancer death worldwide. On average, incidence rates for gastric cancer are 2 to 3 time higher for men than women. Objective: In this study we aimed to evaluate the knowledge on clinical and pathologic features of Gastric carcinoma among Libyan patients. Methods: This is a descriptive retrospective study, all the gastric carcinoma cases diagnosed at the Medical and Surgical Department, `National cancer institute of Sabratha, Libya between January 2010 and December 2017 were included in this study. Total of 105 patients aged between 28-85 years old were included in this study. The demographic and clinical data of the gastric carcinoma analyzed for patients’ age, gender, blood group, clinical presentation, also endoscopic examination to detect sit and shape of Tumor and histopathological report to determine histological type of gastric adenocarcinoma .Statistical analysis: All statistical analyses were performed with the Statistical Package for Social Sciences (SPSS) version 19. Student’s chi square test was employed to define association between variables. Result: Among the 105 patients in our present study, the 53 (50.9%) cases were male and 51(49.03%) of cases were female. In our study population also, 34 (32.6%) patients were less than 50 years of age and 70(67.3%)patients were more than or equal to at 50years of age .The majority of patients were known blood group (O). Clinicopathological characteristics of study population expected majority of tumor were poorly differentiated (60.8%), and (59.6%) of patients presented with advanced gastric carcinoma .
Downloads
References
1. Khazaei S, Rezaeian S, Soheylizad M, Khazaei S, Biderafsh A. Global incidence and mortality rates of stomach cancer and the human development index: an ecological study. Asian Pacific Journal of Cancer Prevention. 2016 Apr 1;17(4):1701-4.
2. Globocan 2020 database .available online : https://gco.iarc.fr
3. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1. 0, cancer incidence and mortality worldwide: IARC. Cancer Base. 2013;11.
4. Tavares A, Gandra A, Viveiros F, Cidade C, Maciel J. Analysis of clinicopathologic characteristics and prognosis of gastric cancer in young and older patients. Pathology & Oncology Research. 2013 Jan;19(1):111-7..
5. Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology. 2016 Sep 1;27:v38-49.
6. Lauren P. The two histological main types of gastric carcinoma: diffuse and so‐called intestinal‐type carcinoma: an attempt at a histo‐clinical classification. Acta Pathologica Microbiologica Scandinavica. 1965 Sep;64(1):31-49
7. Aoude M, Mousallem M, Abdo M, Youssef B, Kourie HR, Al-Shamsi HO. Gastric cancer in the Arab World: a systematic review. Eastern Mediterranean Health Journal. 2022; 28(7):521-31.
8. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. International journal of molecular sciences. 2020 Jan;21(11):4012.
9. Yu H, Xu N, Li ZK, Xia H, Ren HT, Li N, Wei JB, Bao HZ. Association of ABO blood groups and risk of gastric cancer. Scandinavian Journal of Surgery. 2020 Dec;109(4):309-13.
10. Qiu MZ, Zhang DS, Ruan DY, Luo HY, Wang ZQ, Zhou ZW, Wang FH, Li YH, Xu RH. A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China. Medical Oncology. 2011 Dec;28(1):268-73.
11. Elzouki AN, Buhjab SI, Alkialani A, Habel S, Sasco AJ. Gastric cancer and Helicobacter pylori infection in the eastern Libya: a descriptive epidemiological study. Arab Journal of Gastroenterology. 2012 Jun 1;13(2):85-8.
12. Evans JA, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, Fisher DA, Foley K, Hwang JH, Jue TL, Lightdale JR, Pasha SF. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointestinal Endoscopy. 2015 Jul 1;82(1):1-8.
13. Barad AK, Mandal SK, Harsha HS, Sharma BM, Singh TS. Gastric cancer—a clinicopathological study in a tertiary care centre of North-eastern India. Journal of Gastrointestinal Oncology. 2014 Apr;5(2):142.
14. Rebai W, Fterich F, Makni A, Ksantini R, Bedioui H, Daghfous A, Chebbi F, Jouini M, Ammous A, Kacem M, Safta B. Early gastric
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Najat. A. Hasan, Wejdan.M. Husein, Mufida .M .Khetresh (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
